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Background: Human schistosomiasis is a significant health problem in Sub-Saharan Africa. In Niakhar, West central
Senegal, the transmission of S. haematobium occurs seasonally between July and November. No control measures
have been implemented despite high prevalence reported in previous studies. This aim of this study was to
i) determine the current prevalence of S. haematobium in children at Niakhar, ii) assess the efficacy of one dose
of PZQ (40 mg/kg) against S. haematobium and iii) monitor reinfection.
Methods: The current study was carried out in a cohort of 329 children aged five to 15 years enrolled from six
villages in Niakhar to determine the efficacy of one dose of PZQ, as well as reinfection. Parasitological screening
was performed in June 2011 to determine the baseline prevalence of S. haematobium, and then a single dose of
PZQ was administered to all selected subjects in the transmission season in August 2011. The efficacy of PZQ
treatment and reinfection were monitored respectively five weeks after in September 2011 and from February to
March 2012.
Results: At baseline, the overall prevalence and the heavy intensity of infection were 73.2 % and 356.1eggs/10 ml
of urine. Significant differences in the prevalence and intensity of S. haematobium infection were noted between
villages. A single dose of PZQ significantly reduced the prevalence of S. haematobium infection from 73.2 % to 4.6 %
and the geometric mean intensity of infection from 356.1 to 43.3 eggs/10 ml of urine. The cure rates ranged from
89.4 % to 100 %. The egg reduction rates also ranged from 77.6 % to 100 %. Two to three months after the period
of transmission, the overall rate of reinfection was 12.6 % and was significantly higher in male children than in
female children. The overall prevalence at this period was 13.8 %, which was significantly lower than the prevalence at
baseline (73.2 %).
Conclusion: The Niakhar study area remains a hot spot of urinary schistosomiasis in Senegal with differences in
transmission between villages. This study suggests that when transmission is strictly seasonal, Praziquantel shows the
expected efficacy in reducing the prevalence and intensity of infection, but also a significant effect on the occurrence
of reinfection.
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Human schistosomiasis remains a significant public
health issue worldwide [1]. Sub-Saharan Africa is the
most affected region, encompassing 90 % of the 207 mil-
lion schistosomiasis cases recorded in the world [1, 2].
The burden of schistosomiasis is exacerbated in low in-
come countries where access to clean water and regular
sanitation systems is limited [3, 4]. The disease is caused
by six Schistosoma species: S. haematobium, mansoni,
japonicum, intercalatum, mekongi and guineensis [5, 6].
In sub-Saharan Africa, S. haematobium and S. mansoni
are the predominant species causing urogenital and
intestinal schistosomiasis, respectively [5, 6]. In areas
with permanent water bodies, these two species can be
co-endemic [7]. By contrast, S. haematobium is only
transmitted in seasonal transmission areas, due to the
fact that only the snail of the genus Bulinus, the inter-
mediate hosts, can resist aestivation during the dry time
of year, unlike the snails of genus Biomphalaria, the
intermediate host of S. mansoni [8, 9].
Currently, in endemic areas, the control of schisto-
somiasis disease is mainly based on chemo-preventative
strategies to prevent morbidity later in life due to the
chronic infection with Schistosoma parasites. School-
aged children and communities at high risk of infection
are targeted. The treatment consists of a single oral dose
of 40 mg/kg Praziquantel (PZQ) after or without a prior
diagnosis of Schistosoma spp. [3, 10]. PZQ is also the
drug of choice for the treatment of schistosomiasis due
to its high efficacy against all schistosome species infect-
ing humans [11].
The implementation in the past 10 years of national
control programs based on mass PZQ administration in
school-age children, has allowed the significant reduc-
tion in transmission of schistosomiasis in Sub-Saharan
Africa [10]. Despite a few reports of treatment failures
[12, 13], the majority of studies showed good efficacy of
PZQ, with high egg reduction rates (ERRs) in the urine
in foci of intense S. haematobium transmission and
especially in low-to-moderate transmission areas where
the risk of reinfection is generally low [14–16].
The rate and intensity of post-PZQ chemotherapy
reinfection varies between schistosome species, the
dynamic of the transmission and the level of endemicity
[15]. In areas of permanent schistosomiasis transmission,
the efficacy of the treatment is enhanced when PZQ is
administered when the level of disease transmission is
low [17]. In southwestern Niger, the effectiveness of
treatment with a single dose of PZQ was better in the
village located along a temporary pond than in the
village near an irrigated area of the Niger River Valley
where the transmission is permanent [18].
In Senegal, S. haematobium and S. mansoni coexist in
3 regions: the region of the Senegal River Basin (SRB)[19], Kolda [20] and Kedougou [21], respectively in the
north, south and south east of the country. The disease
is most prevalent along the Senegal River Basin where
the prevalence can reach 95 % due to the permanence of
transmission, since contact with water is inevitable [7].
In these villages around the SRB and the “lac de
Guiers”, several previous studies evaluated the efficacy of
one or repeated treatments and monitored the reinfection
rates. The results showed a high efficacy of PZQ against
S. haematobium infections but reinfection occurred
rapidly and the prevalence could reach the pre-treatment
level [7, 22, 23]. This makes it difficult to control and
eliminate the disease in this region despite the many
efforts following the outbreak of Richard-Toll [24].
These are the reasons that new approaches to biological
control of schistosomiasis are under experimentation in
the SRB [25, 26].
By contrast, most parts of the country, except the
region of Dakar (the capital), only S. haematobium is
endemic in the ten other regions and the disease is most
prevalent in school-age children [27]. In these regions,
the prevalence of urinary schistosomiasis is increasing
because of the absence of regular treatments, the oppos-
ite of what is happening in the SRB. No information is
available on the efficacy of PZQ against S. haematobium
and reinfection after treatment in these settings where
the disease occurs seasonally in temporal ponds and/or
backwaters during the rainy season in Senegal. This is
the case in the Fatick region, where in 1996, the preva-
lence ranged from 3 % to 31 % in some villages of the
region [27]. In other parts of the region, more recent
studies have shown an increased prevalence of up to
39.6 % in 2007 [28] and more than 50 % in 2009 [29].
In the Niakhar area, in central Senegal, the hydro geo-
graphical system is only constituted by temporary ponds
and backwaters. S. haematobium transmission occurs
seasonally between July and November with high preva-
lence and intensity of infection [29]. The population of
Niakhar has no access to PZQ and until now, no mass
drug administration against S. haematobium has been
performed. The aims of the present longitudinal study
were to assess the efficacy of PZQ-based treatment




The study was carried out at Niakhar district (14°30 N,
16°30 W), a demographic survey site located in the
region of Fatick (West central Senegal), 135 km east of
Dakar, the capital of Senegal, in West Africa. The rainy
season spans four months (July through October) [30].
The area is a seasonal transmission focus of urinary schis-
tosomiasis. S. haematobium transmission sites consisted
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December. In the middle of winter, the area is separated
from south to north by the backwater that persists during
the dry season. The ponds dry up faster than the backwa-
ters. From January until the end of June, the population of
Niakhar is not exposed to S. haematobium, as all water
collections are dry. The study population included school-
age children between 5 and 15 years of age enrolled from
six villages of Niakhar: Gajak, Godel, Logdir, Sass njafaj,
Ngalagne kop and Puday. In the villages of Gajak and
Godel the backwaters are used especially for bathing,
swimming, laundry, fetching water, washing pets and fish-
ing while in Sass njafaj, Ngalagne kop, Poudaye and Logdir
those activities are done in the ponds, except fishing. Geo-
graphical positions of the main water points and the
houses selected in each village surveyed were determined
using a global positioning system (GPS). The hydrological
network varies from village to village. It is very dense at
Ngalagne kop, Puday and Logdir where the ponds are near
the houses. At Sass njafaj ponds are rare and far from the
houses. The same situation is observed at Godel where the
populations use one pond, but which is near the houses.
At Gajak, there is no pond but the village is bordered by a
large backwater near the houses (Fig. 1). There was no
mass PZQ administration before the study. A more de-
tailed description of the Niakhar study area has been given
elsewhere [29, 31].
Treatment
Praziquantel was given by Merck KGaA; Darmstadt,
Germany to the World Health Organization (WHO) for
mass distribution by the national program in the fight
against schistosomiasis in Senegal. The Niakhar study
area is one of the sites selected for five rounds of annual
mass treatment against schistosomiasis based on the
prevalence of urinary schistosomiasis higher than 50 %
[29]. This study took place a year before the beginning
of mass treatments in the study zone. The drug was
made available to us by the national program and was
administered at the standard dose of 40 mg/kg at the
health centers of the study zone, and in the presence of
a nurse and an agent from the national program.
Study design
This study is a longitudinal cohort survey before and
after treatment with PZQ. The six villages were enrolled
based on their S. haematobium prevalence reported in a
previous study [29]. The study was conducted between
June 2011 and March 2012. The inclusion criteria were:
i) residence in the studied villages during the rainy sea-
son, ii) an age of between 5 and 15 years and iii) consent
to participate in the study. At the beginning of the study,
in June 2011, the population of study was not in contact
with water collections because the Niakhar area was dryfrom December 2010 to June 2011. The study was con-
ducted in three successive phases with the same children
surveyed at each point of time (Fig. 2):
– Study of the baseline prevalence of S. haematobium
in Niakhar: this phase was conducted in June 2011,
before the beginning of the 2011 transmission
season. At these points in time, a baseline urine
examination was conducted in all children selected
for the study. A child is considered infected by
S. haematobium if at least one egg is found in a
urine sample during microscopic observation.
– Monitoring the efficacy of PZQ treatment: in early
August 2011, after the baseline phase, PZQ (40 mg/kg)
was administered to all children selected, whether
infected or not. The treatment was done in the
middle of the transmission season because PZQ was
not available between June and July. Five weeks
after treatment, in September 2011, one urine
sample was collected from each child to assess the
efficacy of the treatment. Any individual was
considered cured if no egg was found in the urine
sample examined.
– Monitoring reinfection: reinfection was monitored
from February to March 2012 when all water
collections are totally dry and S. haematobium
transmission does not occur. Urine samples were
collected to determine the rate of reinfection. This
monitoring of reinfection involved only children
who were positive and subsequently became
negative and then positive again. Each negative
individual during the September 2011 survey of
PZQ treatment efficacy was considered reinfected if
at least one egg was found in the urine sample.
Urine Sample collection and microscopic analysis for the
detection of S. haematobium eggs
Urine samples were collected door-to-door between
10:00 am and 2 p.m., and transferred to the Niakhar
laboratory for parasitological analysis during the same
day. The urine sample was shaken to ensure the disper-
sal of eggs and then ten milliliters were taken and
filtered through a Millipore® SX0001300 Swinnex® Syringe
Filter. Filtration was followed by microscopic examination
for detection of S. haematobium eggs according to the
method developed by Plouvier et al. [32]. The infection
intensity was classified as light (1–49 eggs/10 ml of
urine) or heavy (≥50 eggs/10 ml of urine), as defined by
the World Health Organization [33].
Ethical approval
The study was part of a larger investigation on schisto-
somiasis epidemiology, transmission and control in Senegal
and which was approved by the Senegalese National Ethics
Fig. 1 Map of the Niakhar study area showing the water points and the houses in the villages investigated
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Fig. 2 Study design
Senghor et al. Parasites & Vectors  (2015) 8:362 Page 5 of 11Committee (reference No.SN11/57). The objectives of
the study were explained to the children and to their
parents or legal guardians, from whom written in-
formed consent was obtained.
Statistical analysis
Data from each village were recorded using Epi-Info,
version 3.5.1 and analyzed using STATA 11.1. The rela-
tionships between characteristics of S. haematobium
infection (prevalence, intensity and reinfection) and
other variables, such as the location of villages and the
sex and age of children, were tested at baseline. Prevalence
comparisons were performed using the chi-squared test
and Fisher’s exact modification of the 2 × 2chi-squared test
[34]. For infection intensity values, the Geometric Means
of Williams was used to calculate the Geometric Eggs
Mean Count (GEMC) in only positive individuals. PZQ
efficacy was measured by determining both cure rate (CR)
and egg reduction rate (ERR). The CR is the percentage of
children positive for egg-patent infection becoming nega-
tive after treatment. The ERR is the percentage reduction
in GEMC, as measured by S. haematobium eggs, after
drug treatment of children with egg-patent infections at
baseline. The ERR was calculated as [1 − (GEMC after
treatment/ GEMC before treatment)] × 100 [35]. GEMC
among different groups was compared using ANOVA. In
all case, a P- value < 0.05 was taken to indicate statistical
significances.
Results
Baseline prevalence and intensity of S. haematobium
infection by village, sex and age
Six villages Gajak, Godel, Logdir, Ngalagne, Puday and
Sass njafaj were selected for the study. A total of 329
subjects were enrolled at baseline. The average age and
the sex ratio m/f were 8.8 (SD, 3.1) years and 1.4, re-
spectively. The population was arbitrarily classified into
three age groups: 5 to 7, 8 to 10 and 11 to 15 years.
Table 1 summarizes the demographic characteristics of
the cohort.
Among the 329 individuals examined at baseline, 241
(73.2 %) were infected by S. haematobium and the other88 were negative (Table 2). The prevalence of S. haema-
tobium infection was 92.3 %, 80.5 %, 78.8 %, 71.4 %,
61.5 % and 50 % at Ngalagne kop, Logdir, Gajak,
Poudaye, Godel and Sass njafaj, respectively. The GEMC
varied from 1573.9 eggs/10 ml of urine in the village of
Ngalagne kop to 128.3 eggs/10 ml of urine in Logdir.
Significant differences in the prevalence and intensity of
infection were noted between villages (p < 0.001). The
infection rate was higher in males (80.2 %) than females
(64.1 %) (p < 0.05). The same trend was observed with
the GEMC, which was 544.1 and 177.0 eggs/10 ml of
urine for males and females, respectively. Significant dif-
ferences in prevalence and GEMC according to sex were
noted (p < 0.05) (Table 3). Prevalence increased accord-
ing to age with 62.4 %, 80.9 % and 81.9 % in the 5 to 7, 8
to 10 and 11 to 15 age groups, respectively. But the
GEMC was higher in the 8 to 10 year age group. Signifi-
cant differences in the prevalence and intensity of infec-
tion were noted between the 5 to 7 year age group and
the others (p < 0.001) (Table 3).
Efficacy of PZQ against S. haematobium according to
village, sex and age
Among the 241 infected children, 237 were treated and
monitored for PZQ efficacy. Four children were not
treated due to their absence and are excluded in the
study but they were referred to health centers where the
rest of PZQ was left. A total of 222 children were egg
negative after treatment. The overall CR and ERRs were
93.7 % and 87.8 %, respectively. After treatment, the
overall prevalence and the GEMC were significantly
reduced. The prevalence of S. haematobium infection
decreased from 73.2 % to 4.6 % (p < 0.05). Significant
decreases in prevalence were noted in each village (p <
0.05). Prevalence after PZQ treatment was 9.8 %, 7.3 %,
2.3 %, 2 %, 1.9 % and 0 %, in the villages of Ngalagne
kop, Gajak, Sass njafaj, Godel, Puday and Logdir, re-
spectively. The same trend was observed with the inten-
sity of infection. The GEMC decreased from 356.1 to
43.3 eggs/10 ml of urine (p < 0.05). CRs were high in all
six villages and varied from 89.4 % at Ngalagne kop to
100 % at Logdir. The ERRs were also high and ranged







Gajak 98 7.8 (2.6) 0.8
Godel 52 8.2 (2.8) 0.8
Logdir 31 8.5 (3.2) 0.6
Ngalagne kop 52 9.1 (2.8) 1.5
Puday 52 8.3 (3) 1.5
Sass ndiafaj 44 9.5 (2.7) 1.3
Total 329 8.8 (3.1) 1.4
aStandard Deviation
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cant difference was observed in the CR and ERRs be-
tween villages (p > 0.05) (Table 2).
In the 237 positive children treated, 222 were totally
cured and eggs were found in urine samples of only 15
(6.3 %) children. Among these 15 children at baseline,
five had excreted over 49 eggs/10 ml of urine and three
of them lived in the village of Ngalagne kop where the
highest GEMC (1 573.9 eggs/10 ml of urine) was re-
corded during this study.
The efficacy of PZQ against S. haematobium infection
based on age is shown in Table 3. After treatment, a sig-
nificant reduction in the prevalence was observed. In
each age group, pre-treatment prevalence was signifi-
cantly reduced from 62.4 % to 4.2 %, 80.9 % to 7.7 % and
81.9 % to 1.2 % in the 5 to 7, 8 to 10 and 11 to 15 age
groups, respectively (p < 0.05). The highest CR (96.9 %)
and ERR (94.3 %) were recorded in the 11 to 15 age
group. These parameters were lowest in the 8 to 10 year
age group and were at 91.7 % and 85.3 % for the CR and
ERRs, respectively. But there was no significant differ-
ence in the CR between age groups (p < 0.05). The re-
sults broken out by sex are also available in Table 3.
Reinfection by villages, sex and age
The study of reinfection involved the 222 children who
were cured after PZQ administration. Among these chil-
dren who were negative after control of the treatment in
September 2011, 28 (12.6 %) reinfection cases from the
2011 transmission season were detected from February
to March 2012. The overall prevalence in the population
at this point in time was 13.8 (Table 2). No reinfection
occurred in the village of Sass where the lowest baseline
prevalence was recorded. In the other villages, reinfec-
tion rates were 37.1 %, 11.9 %, 10.3 %, 8 % and 3.2 %, at
Puday, Ngalagne kop, Gajak, Logdir and Godel, respect-
ively. The patterns of reinfection with S. haematobium
showed statistical difference between villages (p < 0.001).
Compared to the baseline, in each village, the prevalence
was significantly lower after the period of reinfection (p
< 0.05). The overall GEMC (48.3 eggs/10 ml of urine)was significantly lower than the baseline (356.1 eggs/
10 ml) (p < 0.001) (Table 2). The reinfection rate was sig-
nificantly higher in males (12.7 %) than in females
(5.7 %) (p < 0.05). The reinfection rate was more signifi-
cant in children aged 5 to 7 years (17.1 %) than in the
groups of 8 to 10 and 11 to 15 which had quite quanta-
tive statement reinfection rates: 10.5 % and 9.4 %, re-
spectively. However, there was no significant difference
in S. haematobium reinfection between the different age
groups (p > 0.05) (Table 3).
Discussion
In the present study, high prevalence and GEMC of S.
haematobium infection are observed at baseline in the
area of Niakhar. These results are in line with a recent
investigation that has shown high prevalence and inten-
sity of S. haematobium infection in the Niakhar district
[29]. This high level of infection also confirms that Nia-
khar is a hot spot for S. haematobium transmission in
Senegal. In endemic areas, the level of S. haematobium
transmission is very significant in school-age children
between 5 and 15 years of age [36]; this may explain the
high prevalence noted in this study, which targeted only
school-age children. This epidemiological situation in
Niakhar, marked by a high level of urinary schistosomia-
sis transmission is also attributable to the lack of health
education, poor sanitation and also the lack of safe water
resulting in permanent contact with ponds and backwa-
ters which are the main areas of S. haematobium trans-
mission during the rainy season. In addition, before this
investigation, no strategy, i.e. PZQ mass administration,
has been implemented to control the transmission of the
disease [14].
In this study, a high prevalence of S. haematobium
was noted in all the study areas; however, the level of in-
fection was heterogeneous between villages. The distri-
bution of ponds and backwaters may result in
heterogeneity in the prevalence and intensity of S. hae-
matobium infections between study sites. This may have
implications for the heterogeneity found in the transmis-
sion of the disease in Niakhar, where the highest level of
S. haematobium infection was recorded in villages with
the highest density of ponds and backwaters which are
near the households like at Ngalagne kop, Logdir, Gajak,
Puday. The lowest level of transmission is found in Sass
njafaj, which has a poor pond system with limited fre-
quentation by the population. Therefore, the results of
this study indicate once again the importance of the
hydrogeographical network in the epidemiology and
transmission of S. haematobium [37, 38]. This hetero-
geneity between villages may also be explained by access
to tap water present in some households in Niakhar, or
by social behavior [29]. In the Niakhar study area, it has
been shown that the level of frequentation of ponds and
Table 2 The prevalence and intensity of S. haematobium infections in children from six villages in the Niakhar study area in Central Senegal before treatment with PZQ, 5 weeks
post treatment and reinfection levels at 2 to 3 months after draining of ponds and backwater
Characteristics S. haematobium infection
Villages Gajak Godel Logdir Puday Ngalagne kop Sass njafaj Total P-value
Baseline (June 2011)
No. of children infected/examined 77/98 32/52 25/31 37/52 48/52 22/44 241/329 <0.001
Prevalence (95 % CI) 78.6 % (67.2-83.8) 61.5 % (47.9-73.5) 80.6 % (63.7-90.8) 71.1 % (57.7-81.6) 92.3 % (81.8-96.9) 50 % (35.8-64.2) 73.2 % (68.2-77.2)
Numbers of infected children treated
with PZQ
75 32 25 36 47 22 237
GM egg count/10 ml of urine (95 % CI) 169.8 (119.2-241.8) 189.3 (105.6-339.4) 128.3 (73.8-222.8) 966.6 (581.2-1607.5) 1573.9 (1208.2-2050.4) 276.8 (132.2-580.1) 356.1 (286.1-443.3) <0.001
Treatment (August 2011)
Follow-up efficacy of PZQ 5 weeks post
treatment (in September 2011)
No. of children infected/examined 7/96 1/52 0/31 1/51 5/51 1/44 15/325
Prevalence (95 % CI) 7.3 % (3.6-14.3) 2 % (0.3-10.3) 0 % (0–11) 1.9 % (0.3-10.1) 9.8 % (4.2-20.6) 2.3 % (0.4-11.8) 4.6 % (2.7-7.4) 0.219
Numbers of infected treated examined 75 32 25 36 47 22 237
No of children cured (CR in %) 68 (90.6 %) 31 (96.8 %) 25 (100 %) 35 (97.2 %) 42 (89.4 %) 21 (95.4 %) 222 (93.7 %) 0.7
GM egg count/10 ml of urine (95 % CI) 38.1 (9.1-159) 30.0 . 35.0 64.9 (25.2-167.6) 25.0 43.3 (23.1-81.2) 0.144
ERR in % 77.6 % 84.1 % 100 % 96.4 % 95.9 % 90.9 % 87.8 % 0.92
Reinfection after treatment (September
to November 2011)
Follow-up reinfection 2 to 3 months after
transmission period in February and
March 2012
No. of children infected/examined 15/96 2/52 2/31 14/51 11/51 1/44 45/325
Prevalence (95 % CI) 15.6 % (9.7-24.2) 3.8 % (1.1-12.9) 6.4 % (1.8-20.2) 26.9 % (16.7-40.2) 21.7.% (12.5-34.6) 2.3 % (0.4-11.8) 13.8 % (10.5-18) 0.002
GM egg count/10 ml of urine (95 % CI) 99.9 (45.1-221.3) 215.6 (0–1.1e + 13) 462.5 (0–5.7e + 11) 30.7 (10–94.5) 12.0 (4.4-33.1) 506.0 48.1 (26.6-86.8) 0.01
No. of children re-infected/surveyed 8/89 1/51 2/31 13/50 6/46 0/43 30/310











Table 3 The prevalence and intensity of Schistosoma haematobium infections in children from six villages in the Niakhar study area in Central Senegal at baseline, 5 weeks post
treatment and reinfection levels at 2 to 3 months after draining of ponds and backwater, relative to gender and age
Characteristics S. haematobium infection
Gender Age
Variables Female Male P-value 5 - 7 years 8 - 10 years 11 - 15 years P-value
Baseline (June 2011)
No. of children infected/examined 91/142 150/187 88/141 85/105 68/83
Prevalence (95 % CI) 64.1 % (55.9-71.5) 80.2 % (73.9-85.3) 0.001 62.4 % (54.2-69.9) 80.9 % (72.4-87.3) 81.9 % (62.3-88.7) 0.001
Numbers of infected subject treated with PZQ 91 146 88 83 66
GM egg count/10 ml of urine (95 % CI) 177.0 (123.4-253.8) 544.1 (421.4-702.6) 0.001 238.9 (164.4-347.3) 455.6 (313–662.9) 438.7 (299.1-643.3) <0.001
Treatment (August 2011)
Follow-up efficacy of PZQ 5 weeks post
treatment (in September 2011)
No. of children infected/examined 3/142 12/183 6/141 8/103 1/81
Prevalence (95 % CI) 2.1 % (0.7-6) 6.5 % (3.7-10.9) 0.080 4.2 % (1.9-8.9) 7.7 % (3.9-14.4) 1.2 % (0.2-6.7) 0.200
No. of infected treated examined 91 146 88 83 66
No of children cured (CR in %) 88 (96.7 %) 134 (91.8 %) 0.7 82 (93.2 %) 76 (91.7 %) 64 (96.9 %) 0.5
GM egg count/10 ml of urine (95 % CI) 15.7 (3.7-65.4) 55.8 (25.5-112.9) 0.06 26.5 (8–87.7) 67.0 (26.9-166.5) 25.0 0.109
ERR in % 91.1 % 89.7 % 0.99 88.9 % 85.3 % 94.3 % 0.99
Reinfection after treatment
(September to November 2011)
Follow-up reinfection 2 to 3 months after
transmission period in February and
March 2012
No. of children infected/examined 11/142 34/183 22/141 14/103 9//81
Prevalence (95 % CI) 7.7 % (4.3-13.3) 18.6 % (13.1-24.8) 0.010 15.6 % (10.5-22.5) 13.6 % (8.2-21.5) 11.1 % (5.9-19.8) 0.486
GM egg count/10 ml of urine (95 % CI) 37.4 (37.4-12.38) 52.4 (25.2-109.2) 0.012 73.1 (31.8-168.3) 27.8 (9.4-82.4) 38.6 (5.6-263.7) 0.307
No. Of children re-infected/surveyed 8/139 22/173 16/135 8/96 6/81
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contact with these water collections is more significant
in male children, particularly those between 8 and
12 years of age [29]. Therefore, this could explain the
difference in infection observed in male children com-
pared to females and the highest prevalence in boys be-
tween the 8 to 10 and 11 to 15 years age groups. This
situation in Niakhar required implementation PZQ mass
administration targeting each year children aged 5 to
15 years and also health education to reduce contact
with infested water.
Until now, the efficacy of control strategies based on
PZQ mass administration is poorly documented in season-
ally S. haematobium transmission foci in Senegal. This
study revealed that a single dose of 40 mg/kg of PZQ sig-
nificantly reduced the infection prevalence and intensity in
all villages of the study area, confirming the efficacy of PZQ
in the treatment of urinary schistosomiasis. The CR and
ERRs obtained are higher than those observed in previous
studies conducted in seasonal S. haematobium transmission
foci [37] despite that the fact that the treatment was done
during the transmission period due to the none accessibility
of PZQ after baseline survey in June and July.
Indeed, to better assess the impact of treatment, PZQ
should be administered during the low or non-transmission
period. However, this does not affect the treatment out-
come, since in Niakhar the transmission of S. haematobium
is strictly seasonal and occurs from July to November;
hence the adult worms from the previous transmission pe-
riods were exposed to the August 2011 PZQ treatment.
However, the collection of one urine sample per child due
to limited resources could be a limit explaining the high CR
obtained in this Niakhar study. The examination of two or
more urine samples per child on different days and more
than filtration should be more appropriate for estimating
the CR and ERR because of the day-to-day variation in egg
excretion in urine [39].
Five weeks after treatment, eggs were found in 6.3 % of
treated children in this study, particularly in the boys group,
where the highest pre-treatment GEMC was observed. The
same trend was also observed in young Gambians [37]. In
this Niakhar study, for each child, the PZQ was given under
the supervision of a nurse at the health center; therefore,
the probability that these excreted eggs come from non-
compliance with PZQ is unlikely. However, egg excretion is
very common after treatment with PZQ [15] and S. haema-
tobium eggs that have been dead for some time can be ex-
creted some months after the drug administration [40].
Therefore, to fully assess PZQ efficacy, it would more ap-
propriate to determine by hatching the viability of the eggs
still being excreted by some individuals.
The treatment period could also be the cause of the
presence of eggs in these children. Indeed, an infection
could occur between July and August 2011 just beforePZQ administration and when the rainfall and the fre-
quentation of transmission sites are high. The PZQ ad-
ministered during this period is not effective against the
immature stages of the parasite infecting the children
[41]. These immature forms could reach the adult stage
and their eggs can be detected during evaluation of the
efficacy of PZQ in September 2011. Therefore, this rate
of egg excretion after treatment could be very low or
even zero if the treatment was administered during non-
transmission period between March and May and the
control carried out before July, in addition to the egg
viability assessment.
The present study nevertheless shows the difficulty
with a single dose of PZQ to cure totally some children
in whom the intensity of the infection was very high be-
fore treatment [42]. A supplementary dose of PZQ could
be necessary to completely cure this category of infected
individuals in the Niakhar study area. However, in this
strictly seasonal transmission area there was no differ-
ence in the CR and ERRs of S. haematobium between
villages after PZQ treatment. It seems that these param-
eters were not linked to the intensity of infection in the
villages at baseline before administering PZQ. These re-
sults are contrary to those observed in highly endemic
villages in Côte d’Ivoire where transmission is perman-
ent [43] and indicate a clear association between PZQ
efficacy and infection intensity prior to treatment for S.
mansoni [44].
The use of PZQ always remains a valuable strategy for
morbidity prevention and the control of S. haematobium
transmission. Indeed, prevalence and infection intensity
after reinfection decreased significantly compared to the
baseline because a low rate of reinfection was observed at
the end of the 2011 transmission season in the study village.
This low level of reinfection could be explained by a low
level of transmission in the study site but also by the fact
PZQ treatment considerably reduced children harboring
eggs, thus resulting in a decrease of the snails infection
[45]. Another factor might be the ecology of the area, which
is characterized by a short transmission period and that
some children may have the chance of being infected in an
interval of one or even two years. Few infections were re-
ported in an area where transmission sites were composed
of seasonal rain-fed ponds when PZQ treatment was ad-
ministered and monitored in the non-transmission period
[37]. This is also the case in some transmission foci where
populations also use only temporal ponds [18, 43]. These
conditions are contrary to what happens in the SRB, where
transmission and reinfection of S. haematobium and S.
mansoni occurs throughout the year and prevalence after
six-month period following treatment can reach the pre-
treatment levels, especially for S. mansoni [7, 23]. During
this study, reinfection is more significant in males than in
females. This difference may be due to cultural, behavioral
Senghor et al. Parasites & Vectors  (2015) 8:362 Page 10 of 11and social factors that put boys in more contact with water
collections than girls [29].
The current results show that the efficacy of PZQ
against S. haematobium was satisfactory and that treat-
ment has a considerable impact on the morbidity due to
eggs and affect the occurrence of reinfection in children
surveyed in all the villages studied. This suggests that
PZQ mass administration between March and May
could be used to significantly reduce child carriers of S.
haematobium and to control the disease in order to
move towards elimination of urinary schistosomiasis in
seasonal foci in Senegal.
Conclusion
The baseline results confirm that urinary schistosomiasis
is a public health problem in the Niakhar District. A sin-
gle dose of 40 mg/kg of PZQ has a significant impact on
the prevalence and the intensity of infection. This paper
suggest that when transmission is not constant and
large-scale as it was in the Senegal River Basin, PZQ
shows the expected efficacy and a significant effect on
the occurrence of reinfection due to the strict seasonal-
ity of transmission. These results provide a basis for
possible implementation of a urinary schistosomiasis
control program in the district of Niakhar but also in
other foci were transmission is only seasonal in Senegal.
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